Memphasys Share Price and Company Fundamentals
Last traded: Yesterday at 5:10 AM
Memphasys Limited develops, manufactures, and sells cell and protein separation devices, and related consumables for the healthcare, veterinary, and biotechnology market sectors in Australia. The company offers Felix system, a device separates sperm from raw semen by electrophoresis process and size exclusion membranes. It also provides RoXsta, a rapid in vitro antioxidant assessment; and AI-Port, an ambient temperature semen transport device for artificial insemination in animals. In addition, the company develops ambient temperature storage product for human sperm; and a medium for human sperm isolation, fertilisation and cryopreservation. Memphasys Limited was incorporated in 2006 and is based in Homebush, Australia.
Key Metrics
PE ratio
-
PB ratio
3.50
Dividend yield
-
Beta
0.26
Market cap
$18.81M
Enterprise value
$18.79M
Company profile
| Industry / Sector | Medical Devices / Healthcare |
|---|---|
| Website | https://www.memphasys.com |
| Mailing address | 34-36 Richmond Road Level 1 Homebush NSW 2140 Australia |
| Phone / Fax | 61 2 8415 7300 / |
Dividends
More: Memphasys Dividend history, yield and payout ratio
Dividend yield
-
Dividend amount
$-
Payout ratio
0.00%
5Y Avg. yield
-%
Memphasys paid $- dividend and the ex-dividend date was -.The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.MEM dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Feb 2026, following are the company executives and directors listed on Memphasys.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Pablo Neyertz | Director of Finance | ||
| Prof. R. John Aitken Ph.D., ScD FRSE | Scientific Director | ||
| Mr. Stefan Ross | Company Secretary |
Profitability and management effectiveness
Profit margin
0.00%
Operating margin
-773.56%
Return on assets
-17.79%
Return on equity
-98.32%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Memphasys is 18.81M and its enterprise value is 18.79M. The enterprise value to revenue ratio of MEM is 35.66. The enterprise value to EBITDA ratio of MEM is -5.93.
The MEM's stocks Beta value is 0.26 making it 74% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Memphasys (MEM)
Memphasys (ASX:MEM) Frequently Asked Questions
1. What is Memphasys's Stock Symbol?
Memphasys trades on ASX under the ticker symbol "MEM".
2. What is Memphasys's stock price today?
One share of MEM stock can currently be purchased for approximately $0.007.
3. How can I contact Memphasys?
Memphasys's mailing address is 34-36 Richmond Road Level 1 Homebush NSW 2140 Australia. The company can be reached via phone at 61 2 8415 7300.
4. What is Memphasys's official website?
The official website of Memphasys is https://www.memphasys.com.